Identification of potential microRNA panels for pancreatic cancer diagnosis using microarray datasets and bioinformatics methods

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  L. Wang,et al.  MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer. , 2019, European review for medical and pharmacological sciences.

[3]  H. Krmac,et al.  A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients , 2019, Scientific Reports.

[4]  H. Kocher,et al.  Pancreatic Cancer , 2019, Methods in Molecular Biology.

[5]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[6]  H. Sudo,et al.  Abstract 510: MicroRNA-8073 as a tumor suppressor and a potential diagnostic and therapeutic target , 2018, Molecular and Cellular Biology / Genetics.

[7]  Anqi Song,et al.  Breast cancer identification via modeling of peripherally circulating miRNAs , 2018, PeerJ.

[8]  Igor Jurisica,et al.  mirDIP 4.1—integrative database of human microRNA target predictions , 2017, Nucleic Acids Res..

[9]  M. Omrani,et al.  A bioinformatics approach for identification of miR-100 targets implicated in breast cancer. , 2017, Cellular and molecular biology.

[10]  M. Makary,et al.  Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers , 2017, Proceedings of the National Academy of Sciences.

[11]  R. Postier,et al.  Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer , 2017, Oncotarget.

[12]  Bin Zhou,et al.  Early detection of pancreatic cancer: Where are we now and where are we going? , 2017, International journal of cancer.

[13]  Xiaoyi Huang,et al.  Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer , 2017, Scientific Reports.

[14]  J. Farrell.  Pancreatic Cysts and Guidelines , 2017, Digestive Diseases and Sciences.

[15]  Tao Zhang,et al.  MicroRNA-4530 promotes angiogenesis by targeting VASH1 in breast carcinoma cells , 2017, Oncology letters.

[16]  A. Goel,et al.  Emerging Role of MicroRNAs as Liquid Biopsy Biomarkers in Gastrointestinal Cancers , 2017, Clinical Cancer Research.

[17]  M. Krstic-Demonacos,et al.  miR-663a regulates growth of colon cancer cells, after administration of antimicrobial peptides, by targeting CXCR4-p21 pathway , 2017, BMC Cancer.

[18]  R. Wolff,et al.  Association of cigarette smoking and microRNA expression in rectal cancer: Insight into tumor phenotype. , 2016, Cancer epidemiology.

[19]  Muhammad Yasir,et al.  microRNA analysis of gastric cancer patients from Saudi Arabian population , 2016, BMC Genomics.

[20]  P. He,et al.  MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD , 2016, BMC Cancer.

[21]  Paula Ribeiro,et al.  miRNet - dissecting miRNA-target interactions and functional associations through network-based visual analysis , 2016, Nucleic Acids Res..

[22]  T. Ohtsuka,et al.  Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL. , 2016, International journal of oncology.

[23]  H. An,et al.  Hsa-miR-1246 and hsa-miR-1290 are associated with stemness and invasiveness of non-small cell lung cancer. , 2016, Lung cancer.

[24]  Neveen Abd El Moneim Hussein,et al.  Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer , 2016, Journal of Cancer Research and Clinical Oncology.

[25]  S. Aggarwal,et al.  Systematic Review Of Burden Of Pancreatic Cancer. , 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[26]  C. Boland,et al.  Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia , 2015, Clinical Cancer Research.

[27]  Hongzhuan Yin,et al.  Sp1-driven up-regulation of miR-19a decreases RHOB and promotes pancreatic cancer , 2015, Oncotarget.

[28]  A. Carrato,et al.  A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs , 2015, Journal of Gastrointestinal Cancer.

[29]  Motohiro Kojima,et al.  MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers , 2015, PloS one.

[30]  Zhihua Liu,et al.  MiRNA-1469 promotes lung cancer cells apoptosis through targeting STAT5a. , 2015, American journal of cancer research.

[31]  Tao Wang,et al.  Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. , 2015, European urology.

[32]  Bin Wu,et al.  Salivary microRNAs Show Potential as a Noninvasive Biomarker for Detecting Resectable Pancreatic Cancer , 2014, Cancer Prevention Research.

[33]  Heng-jun Gao,et al.  Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. , 2014, International journal of clinical and experimental medicine.

[34]  G. A. Ganepola,et al.  Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. , 2014, World journal of gastrointestinal oncology.

[35]  S. Bojesen,et al.  MicroRNA biomarkers in whole blood for detection of pancreatic cancer. , 2013, JAMA.

[36]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[37]  J. Wang,et al.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer , 2014, Clinical and Translational Oncology.

[38]  H. Matsubara,et al.  Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma , 2013, British Journal of Cancer.

[39]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[40]  S. Knudsen,et al.  Cell-Free Plasma MicroRNA in Pancreatic Ductal Adenocarcinoma and Disease Controls , 2012, Pancreas.

[41]  Paul Fockens,et al.  International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.

[42]  Y. Gong,et al.  Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer , 2012, International journal of cancer.

[43]  Tommaso Mazza,et al.  Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers , 2012, PloS one.

[44]  M. Saif,et al.  Early detection of pancreatic cancer. , 2012, JOP : Journal of the pancreas.

[45]  J. Copland,et al.  RhoB mediates antitumor synergy of combined ixabepilone and sunitinib in human ovarian serous cancer. , 2012, Gynecologic oncology.

[46]  Yi Zheng,et al.  A distinct role of RhoB in gastric cancer suppression , 2011, International journal of cancer.

[47]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[48]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[49]  Yeon-Soo Seo,et al.  RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells , 2009, International journal of cancer.

[50]  C. Croce,et al.  MicroRNAs in cancer: small molecules with a huge impact. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  Markus Müller,et al.  Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels into in vitro diagnostics? , 2009, Expert review of proteomics.

[52]  J. Barkin,et al.  Should Patients With a Strong Family History of Pancreatic Cancer Be Screened on a Periodic Basis for Cancer of the Pancreas? , 2009, Pancreas.

[53]  D. Radisky,et al.  Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growth. , 2009, Cancer research.

[54]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[55]  Helen Hickey,et al.  A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. , 2004, The New England journal of medicine.

[56]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[57]  Sudhir Srivastava,et al.  Markers for early detection of cancer: Statistical guidelines for nested case-control studies , 2002, BMC medical research methodology.

[58]  C. Moskaluk,et al.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. , 1997, Cancer research.

[59]  W. Birchmeier,et al.  Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells , 1993, Journal of Cell Science.

[60]  W. Birchmeier,et al.  Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. , 1993, Seminars in cancer biology.